Daniel Bergé, PhD

Post-doctoral Researcher
Google Scholar profile

As a researcher, I am interested in understanding which alterations in brain circuitry are related to psychosis. Specifically, my goals are to determine the abnormalities in brain networks that are associated with symptoms, cognitive deficits and functioning in psychotic disorders such as schizophrenia or bipolar disorder, and which of them can give information about prognosis.

During the last few years my research topics have alternated between neuroimaging study of brain abnormalities in psychosis and the characterization of clinical key determinants of prognosis in first-episode psychosis.

As a psychiatrist in Spain, I have been coordinating a local first-episode psychosis program aimed to improve the attention and care to this population. Since 2017, thanks to a travel grant, I have focused on the research of biological markers of psychosis in diffusion images and resting state thalamic connectivity at the Carter Lab.

Representative Publications

A 12-month study of the hikikomori syndrome of social withdrawal: Clinical characterization and different subtypes proposal.
Á Malagón-Amor, LM Martín-López, D Córcoles, A González, M Bellsolà, Alan R Teo, Víctor Pérez, Antoni Bulbena, Daniel Bergé.
Psychiatry research, March 2018.

Default Mode network aberrant connectivity associated with neurological soft signs in schizophrenia Patients and Unaffected relatives.
L Galindo, D Bergé, GK Murray, A Mané, A Bulbena, V Pérez, O Vilarroya.
Frontiers in psychiatry 8, 298, 2018.

Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study.
D Bergé, Anna Mané, Purificacion Salgado, Romina Cortizo, Carolina Garnier, Laura Gomez, Cristobal Diez-Aja, Antoni Bulbena, Victor Pérez.
Psychiatric Services 67 (2), 227-233, 2015.

Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination.
D Bergé, S Carmona, P Salgado, M Rovira, A Bulbena, O Vilarroya.
European Archives Of Psychiatry And Clinical Neuroscience 264 (4), 271-283, 2014.

Gray matter volume deficits and correlation with insight and negative symptoms in first‐psychotic‐episode subjects.
D Bergé, S Carmona, M Rovira, A Bulbena, P Salgado, O Vilarroya.
Acta Psychiatrica Scandinavica 123 (6), 431-439, 2011.